Elutia Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Elutia Inc., a Nasdaq-listed biotechnology company specializing in drug-eluting biomatrix technologies, announced the grant of 48,000 non-qualified stock options to a new employee as an inducement award under its 2026 Inducement Award Plan. The awards vest over four years and are priced at $1.05, matching the closing stock price on the grant date.